Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2012
05/30/2012CN102481362A 表皮生长因子受体(egfr)与蛋白酶活化受体2(par2)对肠道通透性的调节 Epidermal growth factor receptor (egfr) and protease-activated receptor 2 (par2) on the regulation of intestinal permeability
05/30/2012CN102481361A 用于治疗癌症的组合物和方法 The compositions and methods for treating cancer
05/30/2012CN102481360A 包含聚γ谷氨酸-壳聚糖纳米颗粒的佐剂组合物 Poly-γ-glutamic acid comprising - nanoparticles of chitosan adjuvant compositions
05/30/2012CN102481359A 重组rsv抗原 Recombinant antigens rsv
05/30/2012CN102481358A 对抗蓝舌病毒的异源性引发-加强免疫疗法 Bluetongue virus against heterologous lead - Strengthening immunotherapy
05/30/2012CN102481357A 用氧化还原电位水溶液治疗或预防流感相关疾病的方法 Aqueous solution with a redox potential treatment or prevention of influenza-related illness method
05/30/2012CN102481356A 稳定的经喷雾干燥的免疫原性的病毒组合物 Spray-dried stabilized immunogenic composition of the virus
05/30/2012CN102481355A 用于保护人受试者的重组亚单位西尼罗病毒疫苗 Recombinant subunit West Nile virus for the vaccine to protect human subjects
05/30/2012CN102481354A 肺炎球菌RrgB分化枝的组合物 Pneumococcal RrgB clade composition
05/30/2012CN102481353A Antigenic polypeptide
05/30/2012CN102481352A Immunogenic compositions of staphylococcus aureus antigens
05/30/2012CN102481351A 工程改造的肉毒杆菌神经毒素 Botulinum neurotoxin engineered
05/30/2012CN102481350A 针对猪胸膜肺炎的疫苗和得到这样的疫苗的方法 Vaccine against swine pleuropneumonia and get this vaccine approach
05/30/2012CN102481349A Cna_b domain antigens in vaccines against gram positive bacteria
05/30/2012CN102481348A Bispecific immunocytokine dock-and-lock (DNL) complexes and therapeutic use thereof
05/30/2012CN102481347A 治疗和预防整合素αvβ5相关疾病的方法及组合物 Treatment and prevention of a disease associated with integrin αvβ5 methods and compositions
05/30/2012CN102481341A Proproteins and methods of use thereof
05/30/2012CN102481340A 干细胞靶向 Stem cell targeting
05/30/2012CN102477096A 分子伴侣功能的人肌酸激酶单链抗体 Chaperone function of human single-chain antibody creatine kinase
05/30/2012CN102477095A 一种抗活化巨噬细胞多克隆抗体的制备及对败血症的作用 An anti-activated macrophages polyclonal antibody preparation and the role of sepsis
05/30/2012CN102475887A 玉清宫软胶栓 Yu Qing soft bolt
05/30/2012CN102475886A 新型抗乳腺癌多肽疫苗 The new anti-breast cancer peptide vaccine
05/30/2012CN102205119B Inactivated rabies antigen and preparation method thereof
05/30/2012CN101947317B Large-scale preparation method of H5N1 avian influenza virus-like particle vaccines
05/30/2012CN101920021B Immune-enhanced hepatitis B therapeutic multivalent vaccine and preparation method thereof
05/30/2012CN101892200B Anti-H3N8 subtype equine influenza virus monoclonal antibody and application thereof
05/30/2012CN101886084B Codon-optimized H3HA/XJ3-07 gene and nucleic acid vaccine thereof
05/30/2012CN101850117B Compound immunological adjuvant and vaccine
05/30/2012CN101824088B Inhibition of il-17 production
05/30/2012CN101798347B Monoclonal antibody for resisting high mobility group protein B1
05/30/2012CN101792740B Recombinant baculovirus expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) immunogen gene and preparation method and application thereof
05/30/2012CN101780276B Method for removing residual DNA in hydrophobia vaccine product by utilizing ultrasound combined with EDTA solution
05/30/2012CN101735309B Iridovirus antigen active polypeptide and application thereof
05/30/2012CN101591646B Dendritic cell vaccine for treating human cervical carcinoma
05/30/2012CN101516397B Treatment of multiple sclerosis (MS) with CAMPATH-1H
05/30/2012CN101492711B Uses of MAGEA9 gene
05/30/2012CN101406702B Method for enhancing immunocompetence of nucleic acid vaccine using SOCS1 interfere technique
05/30/2012CN101386648B Neutralizing monoclonal antibodies against B type botulinum neurotoxin, preparation method and use thereof
05/30/2012CN101184778B P-cadherin antibodies
05/30/2012CN101155596B Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
05/30/2012CN101132811B High affinity antibodies against HMGB1 and methods of use thereof
05/30/2012CN101007850B Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
05/29/2012US8188254 C-class oligonucleotide analogs with enhanced immunostimulatory potency
05/29/2012US8188251 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
05/29/2012US8188239 Multivalent carriers of bi-specific antibodies
05/29/2012US8188238 Recombinantly produced antibody
05/29/2012US8188234 1D05 PCSK9 antagonists
05/29/2012US8188233 1B20 PCSK9 antagonists
05/29/2012US8188231 Immunoglobulin with enhanced affinity for Fc gamma R's; immunotherapy; tissue targeted therapy; directed protein evolution
05/29/2012US8188228 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
05/29/2012US8188223 Serum albumin binding proteins
05/29/2012US8188214 Brachyury polypeptides and methods for use
05/29/2012US8188108 Pharmaceutical composition
05/29/2012US8188065 Boldine compounds for promoting bone growth
05/29/2012US8188058 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
05/29/2012US8188051 Metadherin polypeptides, encoding nucleic acids and methods of use
05/29/2012US8187872 Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein
05/29/2012US8187834 For inhibition or reduction of exocytic fusion in a nociceptive sensory afferent cell comprising a Targeting Moiety, a non-cytotoxic protease and a Translocation Domain; pain
05/29/2012US8187819 Methods of identifying compounds that bind TANGO240
05/29/2012US8187817 Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodies
05/29/2012US8187614 Method of using lectins for prevention and treatment of oral and alimentary tract disorders
05/29/2012US8187613 Method of treating allergies using TGF-β1 and allergens
05/29/2012US8187612 Neuromuscular disorders
05/29/2012US8187611 Anti-peptide antibodies that cross react with protective antigen of Bacillus anthracis and uses thereof
05/29/2012US8187610 Streptococcus equi strain
05/29/2012US8187609 Mycovirus, attenuated strain of phytopathogenic fungus, plant disease controlling agent, method of producing mycovirus, method of attenuating phytopathogenic fungus and method of controlling plant disease
05/29/2012US8187607 Hapten-carrier conjugates and uses thereof
05/29/2012US8187606 HPV antigen fusion protein vaccine compositions and uses thereof
05/29/2012US8187605 Means for the inhibition of anti-β1-adrenergic receptor antibodies
05/29/2012US8187604 Methods of treating with anti-factor D antibodies
05/29/2012US8187603 Antibodies to human IL-22
05/29/2012US8187602 Anti-histone H1 monoclonal antibody and hybridoma for the production thereof
05/29/2012US8187600 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses
05/29/2012US8187599 Compositions and methods for suppressing fibrocytes
05/29/2012US8187598 Methods of treating cancer by administering antibodies to CD200
05/29/2012US8187597 Combination therapy for the treatment of ocular neovascular disorders
05/29/2012US8187596 Method of treating asthma or allergy by administering an IL-33 receptor antibody
05/29/2012US8187595 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I
05/29/2012US8187594 Transferrin receptor antibodies
05/29/2012US8187593 FcγRIIB specific antibodies and methods of use thereof
05/29/2012US8187588 Mycoplasma hyopneumoniae bacterin vaccine
05/29/2012US8187587 Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme
05/29/2012US8187585 Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide
05/29/2012CA2616914C Egfr-binding antibody
05/29/2012CA2570062C Lactic bacteria and their use in the prevention of diarrhea
05/29/2012CA2548468C The use of dead cell material obtained from rhodamine-based photodynamic therapy in the treatment or prevention of immunologic disorders, infections and cancers
05/29/2012CA2469623C Composition for the preservation of viruses
05/29/2012CA2455403C Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
05/29/2012CA2403985C Angiogenic onchocerca volvulus proteins and uses thereof
05/29/2012CA2403817C Methods of modulating hair growth
05/29/2012CA2395053C Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
05/29/2012CA2379388C Immunoglobulin fusion proteins
05/29/2012CA2368855C Differentiation of monocytes into functional dendritic cells
05/29/2012CA2361292C A novel chimeric protein for prevention and treatment of hiv infection
05/29/2012CA2343579C Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
05/29/2012CA2338005C Peptide antagonists of zonulin and methods for use of the same
05/29/2012CA2329148C Specific binding proteins for treating canine allergy
05/29/2012CA2321596C Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
05/29/2012CA2268258C Single-chain multiple antigen-binding molecule, its preparation and use
05/24/2012WO2012068540A2 Neutralizing anti-ccl20 antibodies
1 ... 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 ... 1823